Alec Andrew Schmaier, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thrombosis | 7 | 2023 | 2942 | 1.160 |
Why?
|
Receptor, TIE-2 | 1 | 2021 | 176 | 0.750 |
Why?
|
Protective Agents | 1 | 2021 | 150 | 0.720 |
Why?
|
Blood Coagulation | 2 | 2020 | 1154 | 0.570 |
Why?
|
Vascular Diseases | 2 | 2022 | 1161 | 0.560 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1866 | 0.550 |
Why?
|
Angina Pectoris | 1 | 2018 | 959 | 0.460 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2018 | 323 | 0.460 |
Why?
|
Microcirculation | 1 | 2018 | 1272 | 0.440 |
Why?
|
Platelet Membrane Glycoproteins | 3 | 2013 | 284 | 0.440 |
Why?
|
Blood Platelets | 7 | 2024 | 2479 | 0.430 |
Why?
|
Endothelial Cells | 3 | 2023 | 3548 | 0.410 |
Why?
|
Coronary Stenosis | 1 | 2018 | 794 | 0.400 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1303 | 0.400 |
Why?
|
Pulmonary Embolism | 2 | 2024 | 2567 | 0.390 |
Why?
|
Birds | 1 | 2011 | 168 | 0.360 |
Why?
|
Anticoagulants | 4 | 2023 | 4812 | 0.350 |
Why?
|
Vascular System Injuries | 1 | 2011 | 246 | 0.300 |
Why?
|
Arterial Occlusive Diseases | 1 | 2011 | 748 | 0.280 |
Why?
|
src-Family Kinases | 1 | 2009 | 535 | 0.280 |
Why?
|
Hemostasis | 1 | 2009 | 467 | 0.280 |
Why?
|
Coronary Vessels | 1 | 2018 | 3096 | 0.280 |
Why?
|
Mammals | 1 | 2011 | 1132 | 0.260 |
Why?
|
Biological Evolution | 1 | 2011 | 1071 | 0.250 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15501 | 0.240 |
Why?
|
Brain Ischemia | 1 | 2018 | 3049 | 0.240 |
Why?
|
Angiopoietin-1 | 1 | 2024 | 122 | 0.230 |
Why?
|
Lipocalins | 1 | 2024 | 161 | 0.210 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2023 | 91 | 0.200 |
Why?
|
Phosphatidylserines | 1 | 2023 | 188 | 0.200 |
Why?
|
Apolipoproteins | 1 | 2024 | 326 | 0.190 |
Why?
|
Sulfonic Acids | 1 | 2021 | 103 | 0.190 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 172 | 0.180 |
Why?
|
Mice, Knockout | 5 | 2024 | 14416 | 0.170 |
Why?
|
Phospholipids | 1 | 2023 | 786 | 0.160 |
Why?
|
Platelet Adhesiveness | 2 | 2009 | 154 | 0.160 |
Why?
|
Coronary Artery Disease | 1 | 2018 | 6403 | 0.160 |
Why?
|
Thrombopoiesis | 2 | 2010 | 165 | 0.150 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2018 | 344 | 0.130 |
Why?
|
Platelet Function Tests | 1 | 2018 | 271 | 0.130 |
Why?
|
Aniline Compounds | 1 | 2021 | 1069 | 0.130 |
Why?
|
Stroke | 1 | 2018 | 9758 | 0.130 |
Why?
|
Coronary Restenosis | 1 | 2018 | 396 | 0.130 |
Why?
|
Megakaryocytes | 2 | 2010 | 567 | 0.120 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2644 | 0.110 |
Why?
|
Angiotensin I | 1 | 2013 | 56 | 0.110 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2018 | 575 | 0.100 |
Why?
|
Drug-Eluting Stents | 1 | 2018 | 681 | 0.100 |
Why?
|
Epoprostenol | 1 | 2013 | 247 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1459 | 0.100 |
Why?
|
Bird Diseases | 1 | 2011 | 20 | 0.100 |
Why?
|
Poultry Diseases | 1 | 2011 | 26 | 0.100 |
Why?
|
Mice | 11 | 2024 | 81533 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1862 | 0.100 |
Why?
|
Patient Discharge | 1 | 2024 | 3443 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 4021 | 0.090 |
Why?
|
Heart Diseases | 1 | 2023 | 2781 | 0.090 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 983 | 0.090 |
Why?
|
Neoplasms | 1 | 2018 | 22173 | 0.080 |
Why?
|
Integrin alpha2 | 1 | 2009 | 39 | 0.080 |
Why?
|
Chickens | 1 | 2011 | 859 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7581 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2018 | 2751 | 0.080 |
Why?
|
Receptors, Thrombin | 1 | 2008 | 130 | 0.080 |
Why?
|
Proline | 1 | 2009 | 457 | 0.070 |
Why?
|
Humans | 15 | 2024 | 761572 | 0.070 |
Why?
|
Collagen | 3 | 2009 | 2638 | 0.070 |
Why?
|
Lectins, C-Type | 1 | 2010 | 585 | 0.070 |
Why?
|
Animals | 11 | 2024 | 168467 | 0.070 |
Why?
|
Coronary Angiography | 1 | 2018 | 4471 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2192 | 0.070 |
Why?
|
Aspirin | 1 | 2018 | 3133 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3424 | 0.070 |
Why?
|
Arteries | 1 | 2011 | 1123 | 0.070 |
Why?
|
Platelet Activation | 1 | 2009 | 645 | 0.070 |
Why?
|
Inflammation | 2 | 2024 | 10773 | 0.070 |
Why?
|
Recurrence | 1 | 2018 | 8466 | 0.060 |
Why?
|
Lymphatic Vessels | 1 | 2010 | 358 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1250 | 0.060 |
Why?
|
Electrocardiography | 1 | 2018 | 6377 | 0.060 |
Why?
|
Signal Transduction | 4 | 2021 | 23447 | 0.060 |
Why?
|
Risk Factors | 3 | 2024 | 74213 | 0.060 |
Why?
|
Nitric Oxide | 1 | 2013 | 2135 | 0.060 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2006 | 577 | 0.060 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22172 | 0.050 |
Why?
|
Microfluidics | 1 | 2008 | 653 | 0.050 |
Why?
|
Receptors, Lysosphingolipid | 1 | 2024 | 122 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10002 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12690 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6485 | 0.050 |
Why?
|
Sphingosine | 1 | 2024 | 308 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2024 | 507 | 0.050 |
Why?
|
Lysophospholipids | 1 | 2024 | 338 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2010 | 2448 | 0.050 |
Why?
|
Melanoma, Experimental | 1 | 2024 | 560 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 2 | 2010 | 3397 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4513 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2013 | 5112 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13382 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2898 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2024 | 676 | 0.040 |
Why?
|
Tumor Burden | 1 | 2024 | 1893 | 0.040 |
Why?
|
Female | 5 | 2024 | 392686 | 0.040 |
Why?
|
Aged | 2 | 2021 | 169310 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 23996 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58986 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 59255 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 4575 | 0.030 |
Why?
|
MicroRNAs | 1 | 2010 | 3816 | 0.030 |
Why?
|
Acyl Coenzyme A | 1 | 2013 | 56 | 0.030 |
Why?
|
Nitrogen Isotopes | 1 | 2013 | 84 | 0.030 |
Why?
|
Receptor, Bradykinin B2 | 1 | 2013 | 24 | 0.030 |
Why?
|
Bleeding Time | 1 | 2013 | 83 | 0.030 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2013 | 60 | 0.030 |
Why?
|
Propionates | 1 | 2013 | 183 | 0.030 |
Why?
|
Carbon Isotopes | 1 | 2013 | 458 | 0.030 |
Why?
|
Esters | 1 | 2013 | 211 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2013 | 260 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2013 | 392 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 2013 | 301 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2013 | 371 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2024 | 16986 | 0.020 |
Why?
|
Cyclic GMP | 1 | 2013 | 395 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2018 | 64684 | 0.020 |
Why?
|
Male | 3 | 2021 | 360842 | 0.020 |
Why?
|
Adult | 2 | 2021 | 221203 | 0.020 |
Why?
|
Endothelium, Lymphatic | 1 | 2010 | 63 | 0.020 |
Why?
|
Angiotensin II | 1 | 2013 | 849 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1646 | 0.020 |
Why?
|
Leukemia, Basophilic, Acute | 1 | 2009 | 15 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18253 | 0.020 |
Why?
|
Integrin alpha2beta1 | 1 | 2008 | 17 | 0.020 |
Why?
|
Radiation Chimera | 1 | 2009 | 216 | 0.020 |
Why?
|
Cyclic AMP | 1 | 2013 | 1463 | 0.020 |
Why?
|
Protein Binding | 2 | 2010 | 9353 | 0.020 |
Why?
|
Middle Aged | 1 | 2021 | 220920 | 0.020 |
Why?
|
Blood Cells | 1 | 2009 | 305 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 2008 | 771 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 2693 | 0.020 |
Why?
|
Cell Separation | 1 | 2010 | 1720 | 0.010 |
Why?
|
Blood Vessels | 1 | 2010 | 1113 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1674 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2024 | 7879 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2006 | 903 | 0.010 |
Why?
|
Point Mutation | 1 | 2009 | 1595 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2008 | 1674 | 0.010 |
Why?
|
Sulfonamides | 1 | 2013 | 1978 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26127 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2009 | 3088 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2010 | 11530 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3778 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2417 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 3076 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3733 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5869 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2010 | 3701 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4431 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6214 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2010 | 9541 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5205 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2872 | 0.010 |
Why?
|
United States | 1 | 2024 | 72335 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9420 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 18965 | 0.010 |
Why?
|
Liver | 1 | 2009 | 7529 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23741 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 39970 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 5672 | 0.010 |
Why?
|